Literature DB >> 27800569

Classification of high-risk with cardiac troponin and shock index in normotensive patients with pulmonary embolism.

Savas Ozsu1, Muge Erbay2, Zerrin Gürel Durmuş2, Tevfik Ozlu2.   

Abstract

Accurate risk stratification of normotensive patients with acute pulmonary embolism (PE) require further investigation. We aimed to develop a simple model using clinical (shock index) and laboratory findings (cardiac Troponin, echocardiography) to assess the risk of 30-day mortality in normotensive patients with acute PE. In this retrospective study, 489 normotensive patients with acute PE diagnosed objectively. The primary end-point was defined as a all cause 30-day mortality. Shock index was calculated on admission. The primary end-point occurred in 67 (13.7%, 95% CI 10.7-16.8) patients with acute PE. Predictors of complications included elevated cardiac troponin (OR 1.7, 95% CI 1.3-2.2) and shock index (OR 1.3, 95% CI 1.1-1.5) by multivariable analysis. Risk index point was created based on OR. The model identified stages (stage I: 0-1 point, stage II: 2 points and stage III: 3 point) with 30-day mortality rates of 4.3, 19 and 38.6 %, respectively. The shock index and cardiac troponin can be safely used in combination to determine intermediate risk in patients with PE in emergency departmant. The study provided observations that will require prospective validation before the proposed risk score is adopted in clinical practice.

Entities:  

Keywords:  Intermediate risk; Pulmonary embolism; Shock index; Troponin

Mesh:

Substances:

Year:  2017        PMID: 27800569     DOI: 10.1007/s11239-016-1443-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  12 in total

1.  Should scoring rules be based on odds ratios or regression coefficients?

Authors:  Karel G M Moons; Frank E Harrell; Ewout W Steyerberg
Journal:  J Clin Epidemiol       Date:  2002-10       Impact factor: 6.437

2.  Predictive ability of the new 2014 ESC prognostic model in acute pulmonary embolism.

Authors:  Luca Masotti; Grazia Panigada; Giancarlo Landini; Filippo Pieralli; Francesco Corradi; Salvatore Lenti; Rino Migliacci
Journal:  Int J Cardiol       Date:  2015-10-09       Impact factor: 4.164

3.  Effectiveness of prognosticating pulmonary embolism using the ESC algorithm and the Bova score.

Authors:  David Jimenez; Jose Luis Lobo; Covadonga Fernandez-Golfin; Ana K Portillo; Rosa Nieto; Mareike Lankeit; Stavros Konstantinides; Paolo Prandoni; Alfonso Muriel; Roger D Yusen
Journal:  Thromb Haemost       Date:  2016-01-07       Impact factor: 5.249

4.  Value of Cardiac Troponin and sPESI in Treatment of Pulmonary Thromboembolism at Outpatient Setting.

Authors:  Savas Ozsu; Hayriye Bektas; Yasin Abul; Tevfik Ozlu; Asım Örem
Journal:  Lung       Date:  2015-04-04       Impact factor: 2.584

5.  2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

Authors:  Stavros V Konstantinides; Adam Torbicki; Giancarlo Agnelli; Nicolas Danchin; David Fitzmaurice; Nazzareno Galiè; J Simon R Gibbs; Menno V Huisman; Marc Humbert; Nils Kucher; Irene Lang; Mareike Lankeit; John Lekakis; Christoph Maack; Eckhard Mayer; Nicolas Meneveau; Arnaud Perrier; Piotr Pruszczyk; Lars H Rasmussen; Thomas H Schindler; Pavel Svitil; Anton Vonk Noordegraaf; Jose Luis Zamorano; Maurizio Zompatori
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

6.  Prognostic role of the simplified pulmonary embolism severity index and shock index in pulmonary embolism.

Authors:  Talat Kilic; Hilal Ermis; Gazi Gülbas; Omar Kaya; Zeynep A Aytemur; Feyza Inceoglu; Suleyman S Hacievliyagil
Journal:  Pol Arch Med Wewn       Date:  2014-10-10

7.  Haemodynamically unstable pulmonary embolism in the RIETE Registry: systolic blood pressure or shock index?

Authors:  R Otero; J Trujillo-Santos; A Cayuela; C Rodríguez; M Barron; J J Martín; M Monreal
Journal:  Eur Respir J       Date:  2007-09-05       Impact factor: 16.671

8.  Identification of intermediate-risk patients with acute symptomatic pulmonary embolism.

Authors:  Carlo Bova; Olivier Sanchez; Paolo Prandoni; Mareike Lankeit; Stavros Konstantinides; Simone Vanni; David Jiménez
Journal:  Eur Respir J       Date:  2014-04-02       Impact factor: 16.671

Review 9.  Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis.

Authors:  Frederikus A Klok; Inge C M Mos; Menno V Huisman
Journal:  Am J Respir Crit Care Med       Date:  2008-06-12       Impact factor: 21.405

10.  Predictive value of troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism.

Authors:  Savas Ozsu; Yasin Abul; Asim Orem; Funda Oztuna; Yilmaz Bulbul; Huseyin Yaman; Tevfik Ozlu
Journal:  Multidiscip Respir Med       Date:  2013-05-28
View more
  1 in total

1.  Plasma brain natriuretic peptide, platelet parameters, and cardiopulmonary function in chronic obstructive pulmonary disease.

Authors:  Hai-Jian Guo; Feng Jiang; Chu Chen; Jia-Yu Shi; Ya-Wen Zhao
Journal:  World J Clin Cases       Date:  2021-12-26       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.